• (1S,3R)-RSL3 glutathione peroxidase 4 inhibitor: Reliable...

  2026-03-24

  This scenario-driven article provides biomedical researchers and lab technicians with evidence-based guidance on leveraging (1S,3R)-RSL3 glutathione peroxidase 4 inhibitor (SKU B6095) for robust ferroptosis and oxidative stress studies. By addressing real-world experimental challenges, comparing vendor options, and referencing validated protocols, we demonstrate how SKU B6095 ensures reproducibility, sensitivity, and workflow compatibility in cancer biology research.

• Parathyroid hormone (1-34) (human): Atomic Benchmarks for...

  2026-03-24

  Parathyroid hormone (1-34) (human) is a rigorously characterized peptide used as a parathyroid hormone 1 receptor agonist in bone metabolism and calcium homeostasis research. This article provides atomic, verifiable facts to support its experimental applications, clarifies boundaries of use, and integrates the latest advances in kidney assembloid modeling.

• SU 5402: Precision Receptor Tyrosine Kinase Inhibitor for...

  2026-03-23

  SU 5402 stands out as a versatile, potent receptor tyrosine kinase inhibitor, enabling researchers to dissect VEGFR2/FGFR/PDGFR/EGFR signaling in cancer biology and advanced neuronal models. Its robust performance in cell cycle arrest, apoptosis induction, and pathway-specific assays makes it indispensable for translational bench research. Harness the full potential of SU 5402 with optimized workflows, troubleshooting guidance, and cutting-edge applications across oncology and virology.

• Morin (C5297): Natural Flavonoid Antioxidant and Mitochon...

  2026-03-23

  Morin (2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one) is a high-purity natural flavonoid antioxidant characterized by potent bioactivities including antioxidant, anti-inflammatory, and neuroprotective effects. This article defines Morin’s mechanism as a mitochondrial energy metabolism modulator, provides evidence for its application in diabetes and neurodegenerative models, and clarifies its limits as a biochemical probe.

• Methoxy-X04: Fluorescent Amyloid Beta Probe for Alzheimer...

  2026-03-22

  Methoxy-X04 is a brain-permeable fluorescent amyloid beta probe that enables high-contrast, rapid visualization of Aβ plaques and oligomers in neurodegenerative disease models. Its robust labeling and in vivo compatibility make it a gold standard for Alzheimer’s disease research and drug discovery workflows.

• Amyloid Beta-peptide (25-35): Benchmark Tool for Alzheime...

  2026-03-21

  Amyloid Beta-peptide (25-35) (Aβ25-35) is a validated neurotoxic peptide fragment widely employed as a model compound for amyloid-induced neurotoxicity in Alzheimer’s disease (AD) research. This article details its mechanistic role, experimental benchmarks, and workflow best practices, positioning APExBIO’s A1039 kit as an indispensable resource for neurodegenerative disease studies.

• Amyloid Beta-peptide (25-35): A Model Compound for Alzhei...

  2026-03-20

  Amyloid Beta-peptide (25-35) (Aβ25-35) is a validated, neurotoxic peptide fragment widely used as a model for amyloid-induced neurotoxicity in Alzheimer's disease (AD) research. This article presents atomic, verifiable facts about its mechanism, experimental benchmarks, and integration into neurodegenerative disease workflows.

• SU 5402: Precision Receptor Tyrosine Kinase Inhibitor for...

  2026-03-20

  SU 5402 stands out as a potent, selective receptor tyrosine kinase inhibitor, enabling researchers to dissect complex signaling pathways in both cancer and advanced neuronal systems. With robust inhibition of FGFR3, VEGFR2, and PDGFRβ phosphorylation, SU 5402 empowers workflows ranging from multiple myeloma research to human iPSC-derived neuron modeling. Discover how optimized protocols and data-driven strategies maximize reproducibility and insight with this APExBIO flagship inhibitor.

• Morin: Beyond Antioxidant—A Systems Biology Lens on Neuro...

  2026-03-19

  Explore how Morin, a natural flavonoid antioxidant, acts as a systems-level modulator of neuroprotection, mitochondrial metabolism, and disease pathways. This article uniquely integrates mechanistic biochemistry, translational insights, and advanced research applications.

• Parathyroid hormone (1-34) (human): Reliable Solutions fo...

  2026-03-19

  This article provides a scenario-driven, evidence-based guide to using Parathyroid hormone (1-34) (human) (SKU A1129) in reproducible cell viability, proliferation, and bone metabolism assays. Drawing on recent literature and validated best practices, it demonstrates how SKU A1129 addresses common laboratory challenges in kidney and osteoporosis models, with practical guidance for protocol optimization and data interpretation.

• SU 5402: Advanced Receptor Tyrosine Kinase Inhibitor for ...

  2026-03-18

  SU 5402 offers unparalleled versatility as a VEGFR2/FGFR/PDGFR/EGFR inhibitor, empowering researchers to dissect complex signaling in cancer biology and latent viral infections. Its robust performance in inducing cell cycle arrest and apoptosis, combined with unique compatibility for iPSC-derived neuron models, positions SU 5402 from APExBIO as a gold standard in translational research workflows.

• SU 5402: Strategic Pathway Inhibition for Translational R...

  2026-03-18

  This APExBIO thought-leadership article delivers a comprehensive, mechanistic, and strategic roadmap for translational researchers leveraging SU 5402—a potent receptor tyrosine kinase inhibitor targeting VEGFR2, FGFR, PDGFR, and EGFR. By integrating pathways biology, experimental validation, and future-facing guidance, this piece goes beyond standard product pages, uniquely connecting FGFR3 phosphorylation inhibition to cutting-edge cancer and neurovirology research, including innovative models of viral latency.

• Harnessing Ferroptosis: Strategic Deployment of RSL3 (Glu...

  2026-03-17

  This thought-leadership article synthesizes the mechanistic basis and translational value of RSL3, a selective glutathione peroxidase 4 (GPX4) inhibitor and established ferroptosis inducer. By integrating recent insights from hepatocellular carcinoma research, competitive product benchmarks, and workflow guidance, it equips translational researchers with an advanced perspective on leveraging oxidative stress and redox vulnerabilities in oncology. The article explores RSL3’s role in dissecting iron-dependent, non-apoptotic cell death pathways, its unique synthetic lethality with oncogenic RAS, and strategic routes for clinical translation—moving beyond conventional product summaries to actionable, future-focused guidance.

• SU 5402: Precise Receptor Tyrosine Kinase Inhibitor for F...

  2026-03-17

  SU 5402 is a validated, potent receptor tyrosine kinase inhibitor designed for precise inhibition of FGFR3, VEGFR2, PDGFRβ, and EGFR. It is indispensable for dissecting cell signaling in multiple myeloma and cancer biology, supporting robust apoptosis and cell cycle arrest assays.

• RSL3: Precision GPX4 Inhibitor for Ferroptosis in Cancer ...

  2026-03-16

  RSL3, a selective glutathione peroxidase 4 inhibitor, delivers unmatched control over ferroptosis induction for cancer research and redox biology. Learn how APExBIO’s RSL3 empowers reproducible experiments—from workflow optimization to troubleshooting—while unlocking advanced insights into iron-dependent cell death pathways.

15193 records 1/1013 page Next 12345 下5页 Last page